TrovaGene News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.06.17	Trovagene Announces Manufacturing Agreement with NerPharMa for Supply of PCM-075 for AML Trial (PR Newswire)
27.06.17	Trovagene Announces Submission of Investigational New Drug Application to Initiate Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (PR Newswire)
26.06.17	Trovagene Announces Expansion of Key Claims for its NPM1 Patent Portfolio for Acute Myeloid Leukemia (PR Newswire)
22.06.17	Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera® ctDNA Tests and Services in Cancer Clinical Trials (PR Newswire)
13.06.17	Pharma and Biotech Companies Significantly Investing in R&D, Focus on Rising Demand for Advanced Medicines (PR Newswire)
13.06.17	Pharma and Biotech Companies Significantly Investing in R&D, Focus on Rising Demand for Advanced Medicines (PR Newswire)
12.06.17	Trovagene Enters Into Agreement with AstraZeneca to Utilize Trovera® ctDNA Test and Services in Prospective Biomarker Study (PR Newswire)
01.06.17	Trovagene to Present at the Marcum 2017 MicroCap Conference on June 15 in New York City (PR Newswire)
25.05.17	Phase 1 Safety Study Supports Planned Development of PCM-075 in AML (PR Newswire)
23.05.17	Trovagene to Present at the 7th Annual LD Micro Invitational Conference on June 7, 2017 in Los Angeles (PR Newswire)
22.05.17	Forcepoint Appoints 20-Year Cybersecurity Veteran as Global Sales Leader (PR Newswire)
10.05.17	Trovagene Announces First Quarter 2017 Company Highlights and Financial Results (PR Newswire)
26.04.17	Trovagene to Announce First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 10, 2017 (PR Newswire)
25.04.17	Trovagene to Present at the Pioneers 2017 Joseph Gunnar Conference on May 2, 2017 in New York City (PR Newswire)
27.03.17	Trovagene to Present at The MicroCap Conference on April 4, 2017 in New York City (PR Newswire)
21.03.17	Trovagene to Present at the Sidoti & Company Spring 2017 Convention (PR Newswire)
17.03.17	Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV... (RTTNews)
15.03.17	Trovagene Reports Fourth Quarter and Year End 2016 Financial Results (PR Newswire)
15.03.17	Trovagene and Nerviano Announce License Agreement for therapeutic candidate PCM-075 (PR Newswire)
01.03.17	Trovagene to Announce Fourth Quarter and Year End 2016 Financial Results and Accomplishments and Host Conference Call on Wednesday, March 15, 2017 (PR Newswire)
28.02.17	Trovagene to Attend the 29th Annual ROTH Conference (PR Newswire)
24.01.17	Publication of Trovera™ KRAS Liquid Biopsy Test Demonstrates Clinical Utility in Advanced Cancers for Detection and Measurement of Therapeutic Response (PR Newswire)
12.01.17	Trovagene Announces Broadening Network of Commercial Distributors (PR Newswire)
13.12.16	Trovagene announces a reorganization to accelerate global distribution of liquid biopsy technology (PR Newswire)
30.11.16	Trovagene and Boreal Genomics Announce Strategic Partnership (PR Newswire)
28.11.16	World Lung Conference Features Data Demonstrating Clinical Utility and Cost Effectiveness of Trovagene's Liquid Biopsy Tests for Mutation Detection and Monitoring in NSCLC Patients (PR Newswire)
22.11.16	Trovagene to Attend the 28th Annual Piper Jaffray Healthcare Conference (PR Newswire)
29.03.16	Trovagene Terminates Its CEO And CFO; Stock Plunges (RTTNews)
17.07.15	Trovagene Expects Gross Proceeds Of $35 Mln. From Public Offering (RTTNews)
20.04.15	ATHX Suffers Another Blow, MRK's Keytruda Proven Superior, TROV Outperforms (RTTNews)
29.09.14	Trovagene Expands Clinical Program - Quick Facts (RTTNews)
21.10.13	First Prospective Cancer Monitoring Data Released - Indicating that Oncogene Mutation Signal in Urine Correlates with Response to Therapy (PR Newswire)
16.10.13	Trovagene announces pharmaceutical collaboration for oncogene mutation detection study (PR Newswire)
01.10.13	First urine-based cancer mutation monitoring test available from Trovagene (PR Newswire)
06.09.13	Trovagene collaborates with USC in clinical study evaluating cancer monitoring technology (PR Newswire)
04.09.13	Trovagene to Present at Two Healthcare Conferences (PR Newswire)
14.08.13	Trovagene, Inc. Announces Second Quarter 2013 Earnings (PR Newswire)
31.07.13	Trovagene, Inc. Announces Closing of $15 Million Registered Direct Offering of Common Stock (PR Newswire)
29.07.13	RainDrop System Unlocks Power of Trovagene's Urine-Based Mutation Detection Technology (PR Newswire)
24.07.13	Trovagene Announces Issuance of Broad MicroRNA Patent (PR Newswire)
23.07.13	Tuesday's Biotech Watch List - Alliqua, BioCryst Pharmaceuticals, Trovagene, Delcath Systems, Array BioPharma (PR Newswire)
22.07.13	Urine-based Cancer Detection Technology Validated (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	81.32	1.78 %	K V
Part Grp Hldg	1’398.50	1.27 %	K V
Kuehne+Nagel Int	205.90	0.64 %	K V
Novartis	90.26	0.59 %	K V
CieFinRichemont	169.05	0.48 %	K V
ABB	53.26	-0.56 %	K V
Sika	226.80	-0.70 %	K V
Geberit	497.10	-0.74 %	K V
Givaudan	3’907.00	-0.96 %	K V
Sonova Hldg	313.20	-1.66 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu TrovaGene Inc

Aktien Top/Flop

Meistgelesene Nachrichten